News North America Senate Stalls On US Cannabis Banking Rules

Senate Stalls On US Cannabis Banking Rules

-

DESPITE widespread political support legislation to allow cannabis businesses access to the country’s banking system seem to have little chance of passing into law anytime soon.

The Secure and Fair Enforcement (SAFE) Banking Act was the first standalone cannabis bill to be passed by a House of Representatives in a near unanimous vote last September. 

However,  the bill has subsequently languished in the Republican-controlled Senate.

Senior Republicans such as Senate Majority Leader Mitch McConnell are vocal opponents and seem unlikely to allow it to progress this side of the Presidential election later this year.  

The lack of progress means many cannabis business will continue to operate in an environment akin to ‘Wild West’ with some having to recruit armed guards to ferry cash.

Existing Federal rules sanction banks from working with registered cannabis businesses even though they operate within the laws of their home state.

However, following the passing of the Farm Bill in 2018 and the legalisation of hemp cultivation strict rules governing banking in this industry have been eased.

Four senior federal financial regulatory agencies recently announced that banks no longer have to take extra steps to track accounts for hemp-related businesses.

The difficulties hemp farmers have encountered are amply demonstrated by this tale of a farming family in Wisconsin, reported on the newfoodeconomy website.

Eight months after setting up their business, and associate bank accounts to run their hemp farm, they were told by the bank that their business activity was ‘outside its established risk tolerances’.

The joint statement released Federal Reserve Board, the Federal Deposit Insurance Corporation, FinCEN, the Office of the Comptroller of the Currency and the Conference of State Bank Supervisors says banks ‘are no longer required to file suspicious activity reports (SAR) for customers solely because they are engaged in the growth or cultivation of hemp in accordance with applicable laws and regulations’. 

The American Bankers Association (ABA) welcomed the announcement saying it had been ‘long sought”  by the financial services industry.

Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse

A PERMANENT solution to the import impasse on children’s epilepsy cannabis medication has emerged with the Dutch manufacturer set...

‘The Dutch Bedrocan Medicine Is The Only Viable Option For Treating Many Children’s Epilepsy’

Prof Mike Barnes, one of the UK's leading cannabis clinicians responds to suggestions that the medicines for UK children...

Amazon Enters CBD Retail Market – But Only In One Country

GLOBAL on-line retail giant Amazon is dipping its toes into the CBD market with the first ever products now...

The UK Medical Cannabis Industry Can – And Does – Provide Epilepsy Medicines For Children In Post-Brexit Britain

Pierre Van Weperen of Grow Pharma on the post-Brexit issue surrounding the import of epilepsy cannabis medicines into the...

Dozens of CBD Brands In A State of ‘Absolute Panic’ With UK Novel Food Deadline Weeks Away

THE New Year has brought a realisation that the Novel Food deadline is less than three months away leading...

Work Gets Underway On Scotland’s First Medical Cannabis Cultivation and Production Facility

SCOTLAND’S first home-grown cannabis medicines could be in UK patients’ hands in early 2022 after work started on a...

Must read

Children’s Dutch Epilepsy Cannabis Medicines Will Be Made In The UK To Overcome Import Impasse

A PERMANENT solution to the import impasse on children’s...

You might also likeRELATED
Recommended to you